Plastic Surgery Doctors in Huntsville, AL Accepting Medicare

4 Plastic Surgery doctors found. Showing 1 - 4

Dr. Lawrence H. Bundrick, MD Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 333 Whitesport Dr Sw Ste 201, Huntsville, AL 35801 Phone: 256-881-8800

Dr. William E. Alison Ii, M.D. Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 303 Williams Ave Sw, Suite 1421, Huntsville, AL 35801 Phone: 256-536-4448    Fax: 256-533-4583

Dr. Michael D. Yates, M.D. Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 303 Williams Ave Sw, Suite 1421, Huntsville, AL 35801 Phone: 256-536-4448    Fax: 256-533-4583

James Stilwell, M.D. Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 9006 Berclair Rd Sw, Huntsville, AL 35802 Phone: 256-882-9511    Fax: 256-881-0908

News Archive

Phase I/II clinical study data of OncoVEXGM-CSF for head and neck cancer published in Clinical Cancer Research

BioVex Inc, a company developing new generation biologics for the treatment of cancer and prevention of infectious disease, announces that the data from its completed Phase I/II clinical study of OncoVEXGM-CSF for the first line treatment of head and neck cancer is being published today in Clinical Cancer Research, an ASCO publication.

Democratic Presidential candidates discuss abortion rights

Eight candidates for the Democratic presidential nomination on Thursday in a debate at South Carolina State University "uniformly criticized" the U.S. Supreme Court's decision last week to uphold a federal law (S 3) banning so-called "partial-birth" abortion, the Washington Post reports (Balz, Washington Post , 4/27).

UL Environment experts to serve as advisory board member of Johns Hopkins Center for Alternatives to Animal Testing

UL (Underwriters Laboratories), a global safety science leader, announced today that UL Environment's Craig Rowlands, PhD, DABT, senior toxicologist, will serve as an advisory board member of Johns Hopkins Center for Alternatives to Animal Testing (CAAT) and UL Environment's Anne Bonhoff, PhD, global head of chemistry, will serve as an advisory board member of the European branch (CAAT-Europe) located at the University of Konstanz, Germany.

Abbvie presents venetoclax Phase 1 results in patients with multiple myeloma at ASCO 2015

AbbVie, a global biopharmaceutical company, today announced that results from a Phase 1b trial of investigational venetoclax, a novel inhibitor of the B-cell lymphoma-2 (BCL-2) protein that is being developed in partnership with Genentech and Roche, in combination with bortezomib and dexamethasone, showed an 83 percent overall response rate (n=5/6) in bortezomib-naive patients with relapsed/refractory (R/R) multiple myeloma, including two patients who achieved complete responses.1 These data will be presented at the American Society of Clinical Oncology (ASCO) Annual Meeting on Sunday, May 31, in Chicago.

Opportunity in European embolization coil market leads to major acquisitions in 2010: MRG

According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, high market opportunity in the European embolization coil market has led to several major acquisitions in 2010. The European market alone was valued at approximately $100 million in 2009, making successful niche competitors in this market attractive acquisition targets.

Read more Medical News

› Verified 8 days ago